ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 150 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $222,560 | -40.2% | 10,400 | +13.0% | 0.01% | -44.4% |
| Q1 2023 | $372,048 | +85823.3% | 9,200 | -1.1% | 0.01% | -25.0% |
| Q4 2022 | $433 | -99.9% | 9,300 | 0.0% | 0.01% | -14.3% |
| Q3 2022 | $482,000 | +6.2% | 9,300 | +4.5% | 0.01% | +16.7% |
| Q2 2022 | $454,000 | -32.7% | 8,900 | 0.0% | 0.01% | -25.0% |
| Q1 2022 | $675,000 | +3.7% | 8,900 | +2.3% | 0.02% | +14.3% |
| Q4 2021 | $651,000 | +31.8% | 8,700 | 0.0% | 0.01% | +16.7% |
| Q3 2021 | $494,000 | +38.8% | 8,700 | +7.4% | 0.01% | +33.3% |
| Q2 2021 | $356,000 | -11.9% | 8,100 | -1.2% | 0.01% | -18.2% |
| Q1 2021 | $404,000 | +17.1% | 8,200 | 0.0% | 0.01% | +10.0% |
| Q4 2020 | $345,000 | -9.2% | 8,200 | -1.2% | 0.01% | -44.4% |
| Q3 2020 | $380,000 | +71.9% | 8,300 | +88.2% | 0.02% | +38.5% |
| Q2 2020 | $221,000 | -2.6% | 4,410 | 0.0% | 0.01% | -18.8% |
| Q1 2020 | $227,000 | -32.8% | 4,410 | -19.4% | 0.02% | -5.9% |
| Q4 2019 | $338,000 | -4.5% | 5,470 | -7.3% | 0.02% | -10.5% |
| Q3 2019 | $354,000 | -29.2% | 5,900 | 0.0% | 0.02% | -24.0% |
| Q2 2019 | $500,000 | -11.3% | 5,900 | 0.0% | 0.02% | -10.7% |
| Q1 2019 | $564,000 | +35.3% | 5,900 | +0.3% | 0.03% | +16.7% |
| Q4 2018 | $417,000 | -29.3% | 5,881 | -14.8% | 0.02% | -4.0% |
| Q3 2018 | $590,000 | -21.6% | 6,900 | +6.2% | 0.02% | -26.5% |
| Q2 2018 | $753,000 | +45.4% | 6,500 | +1.6% | 0.03% | +41.7% |
| Q1 2018 | $518,000 | +44.7% | 6,400 | +4.9% | 0.02% | +50.0% |
| Q4 2017 | $358,000 | +32.1% | 6,100 | +5.2% | 0.02% | +23.1% |
| Q3 2017 | $271,000 | +32.2% | 5,800 | +1.8% | 0.01% | +30.0% |
| Q2 2017 | $205,000 | -2.4% | 5,700 | -1.7% | 0.01% | -9.1% |
| Q3 2015 | $210,000 | – | 5,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 476,042 | $45,472,000 | 12.29% |
| Stonepine Capital Management, LLC | 60,840 | $5,811,000 | 3.34% |
| ACUTA CAPITAL PARTNERS, LLC | 61,000 | $5,827,000 | 2.77% |
| Virtus ETF Advisers LLC | 10,634 | $1,016,000 | 2.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $5,827,000 | 2.15% |
| ARMISTICE CAPITAL, LLC | 372,000 | $35,533,000 | 1.94% |
| Matarin Capital Management, LLC | 209,403 | $20,002,000 | 1.46% |
| Monashee Investment Management LLC | 50,000 | $4,776,000 | 1.10% |
| Granahan Investment Management | 151,322 | $14,454,000 | 0.78% |
| ALGERT GLOBAL LLC | 13,186 | $1,260,000 | 0.72% |